Hill-Rom Holdings, Inc. (NYSE:HRC) Shares Sold by Vigilant Capital Management LLC

Vigilant Capital Management LLC reduced its stake in Hill-Rom Holdings, Inc. (NYSE:HRC) by 52.0% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 600 shares of the medical technology company’s stock after selling 650 shares during the quarter. Vigilant Capital Management LLC’s holdings in Hill-Rom were worth $50,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of HRC. Holocene Advisors LP lifted its holdings in shares of Hill-Rom by 2,812.9% in the 2nd quarter. Holocene Advisors LP now owns 471,051 shares of the medical technology company’s stock worth $51,712,000 after acquiring an additional 454,880 shares during the last quarter. Victory Capital Management Inc. lifted its holdings in shares of Hill-Rom by 23.2% in the 2nd quarter. Victory Capital Management Inc. now owns 2,141,695 shares of the medical technology company’s stock worth $235,116,000 after acquiring an additional 402,960 shares during the last quarter. Bank of America Corp DE lifted its holdings in shares of Hill-Rom by 26.1% in the 2nd quarter. Bank of America Corp DE now owns 1,246,831 shares of the medical technology company’s stock worth $136,877,000 after acquiring an additional 258,311 shares during the last quarter. LSV Asset Management lifted its holdings in shares of Hill-Rom by 3,390.1% in the 2nd quarter. LSV Asset Management now owns 264,547 shares of the medical technology company’s stock worth $29,041,000 after acquiring an additional 256,967 shares during the last quarter. Finally, Silvercrest Asset Management Group LLC purchased a new stake in Hill-Rom during the 2nd quarter worth approximately $17,185,000. Hedge funds and other institutional investors own 86.29% of the company’s stock.

Shares of NYSE:HRC opened at $89.53 on Friday. Hill-Rom Holdings, Inc. has a 52 week low of $72.29 and a 52 week high of $117.68. The company’s 50 day moving average is $87.16 and its two-hundred day moving average is $100.14. The company has a current ratio of 1.50, a quick ratio of 1.16 and a debt-to-equity ratio of 1.08. The company has a market cap of $5.96 billion, a PE ratio of 28.88, a P/E/G ratio of 2.70 and a beta of 0.63.

Hill-Rom (NYSE:HRC) last announced its quarterly earnings data on Friday, July 31st. The medical technology company reported $1.95 EPS for the quarter, beating the Zacks’ consensus estimate of $1.46 by $0.49. Hill-Rom had a net margin of 7.05% and a return on equity of 25.48%. The company had revenue of $767.50 million for the quarter, compared to the consensus estimate of $749.39 million. During the same period in the prior year, the firm posted $1.23 EPS. The company’s quarterly revenue was up 5.6% compared to the same quarter last year. As a group, equities research analysts expect that Hill-Rom Holdings, Inc. will post 5.44 EPS for the current year.

HRC has been the topic of several recent research reports. Morgan Stanley cut their target price on shares of Hill-Rom from $112.00 to $110.00 and set an “overweight” rating on the stock in a research note on Monday, September 21st. Raymond James cut their target price on shares of Hill-Rom from $115.00 to $100.00 and set an “outperform” rating on the stock in a research note on Monday, October 12th. Needham & Company LLC cut their target price on shares of Hill-Rom from $129.00 to $117.00 and set a “buy” rating on the stock in a research note on Tuesday, September 29th. KeyCorp cut their target price on shares of Hill-Rom from $138.00 to $115.00 and set an “overweight” rating on the stock in a research note on Thursday, October 1st. They noted that the move was a valuation call. Finally, ValuEngine downgraded shares of Hill-Rom from a “hold” rating to a “sell” rating in a research note on Monday, August 3rd. One analyst has rated the stock with a sell rating and seven have given a buy rating to the stock. The stock has an average rating of “Buy” and an average target price of $115.29.

In other Hill-Rom news, SVP Andreas G. Frank sold 5,500 shares of the stock in a transaction that occurred on Monday, October 12th. The shares were sold at an average price of $89.48, for a total value of $492,140.00. Following the sale, the senior vice president now directly owns 23,111 shares of the company’s stock, valued at approximately $2,067,972.28. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Corporate insiders own 0.65% of the company’s stock.

Hill-Rom Profile

Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.

Featured Article: Channel Trading

Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings, Inc. (NYSE:HRC).

Institutional Ownership by Quarter for Hill-Rom (NYSE:HRC)

Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.